Mediclinic International PLC (LON:MDC)‘s stock had its “underperform” rating reaffirmed by research analysts at Jefferies Group LLC in a research report issued on Friday, October 27th. They presently have a GBX 550 ($7.23) target price on the stock. Jefferies Group LLC’s price objective would indicate a potential downside of 8.33% from the stock’s current price.
MDC has been the subject of several other research reports. Citigroup Inc. reiterated a “neutral” rating on shares of Mediclinic International PLC in a report on Tuesday, October 24th. J P Morgan Chase & Co lowered Mediclinic International PLC to a “neutral” rating and decreased their price objective for the company from GBX 898 ($11.81) to GBX 733 ($9.64) in a report on Thursday, October 19th. Credit Suisse Group reiterated a “neutral” rating on shares of Mediclinic International PLC in a report on Friday, July 21st. Morgan Stanley lowered Mediclinic International PLC to an “equal weight” rating and decreased their price objective for the company from GBX 825 ($10.85) to GBX 775 ($10.19) in a report on Thursday, June 29th. Finally, Macquarie reiterated a “neutral” rating and set a GBX 660 ($8.68) price objective on shares of Mediclinic International PLC in a report on Thursday, October 26th. Two analysts have rated the stock with a sell rating and seven have assigned a hold rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of GBX 665.33 ($8.75).
Shares of Mediclinic International PLC (LON:MDC) opened at GBX 595.50 ($7.83) on Friday. Mediclinic International PLC has a 1-year low of GBX 577 ($7.59) and a 1-year high of GBX 914 ($12.02).
ILLEGAL ACTIVITY NOTICE: This piece was first posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright legislation. The original version of this piece can be accessed at https://ledgergazette.com/2017/11/13/mediclinic-international-plc-mdc-given-underperform-rating-at-jefferies-group-llc.html.
Mediclinic International PLC Company Profile
Mediclinic International plc is an international private healthcare provider. The Company’s segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services. It has interest in Spire Healthcare, a United Kingdom-based private healthcare company.
Receive News & Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related companies with MarketBeat.com's FREE daily email newsletter.